In order to investigate the anti‐cancer properties of LCRF‐0006, we initially assessed the effect of LCRF‐0006 treatment on the viability of the N‐cadherin‐expressing mouse MM cell line 5TGM1 in vitro. The gene discussed is CDH2; the disease is cancer.